Skip to main content

Table 3 Multivariable predictors of MACEs at 30 days and 3 years stratified by diabetes status

From: Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention

  Variable B Adjusted HR [95%CI] P value
30-day MACE
 All patients APG 0.016 1.016 [1.012, 1.020] <0.001
Creatinine 1.243 3.466 [1.121,10.716] 0.031
Age 0.33 1.034 [1.004,1.065] 0.028
Prior MI 1.442 4.229 [2.314,7.731] <0.001
 Patients without DM APG 0.017 1.018 [1.009,1.027] <0.001
Prior MI 1.714 5.552 [2.211, 13.940] <0.001
Age 0.046 1.047 [1.004,1.092] 0.032
 Patients with DM APG 0.014 1.014 [1.008,1.020] <0.001
Prior MI 1.338 3.813 [1.648,8.819] 0.002
Killip class 3-4 1.186 3.273 [1.299,8.246] 0.012
Prior PCI or CABG 1.728 5.628 [2.285,13.857] <0.001
3-year MACEs
 All patients APG 0.013 1.013 [1.010,1.015] <0.001
LVEF −0.20 0.980 [0.967,0.994] 0.004
Triple vessel disease or LM 0.452 1.572 [1.149,2.151] 0.005
Beta-blockers −0.417 0.659 [0.465,0.935] 0.019
Prior MI 0.558 1.748 [1.212,2.520] 0.003
Age 0.014 1.014 [1.000,1.028] 0.043
 Patients without DM APG 0.017 1.017 [1.013,1.021] <0.001
LVEF −0.029 0.972 [0.954,0.990] 0.002
Triple vessel disease or LM 0.815 2.259 [1.493,3.420] <0.001
Hypertension 0.480 1.617 [1.068,2.448] 0.023
 Patients with DM APG 0.009 1.009 [1.006,1.013] <0.001
Prior MI 1.017 2.765 [1.690,4.525] <0.001
Killip class 3-4 0.637 1.891 [1.090,3.282] 0.024
Creatinine 0.961 2.614 [1.279,5.341] 0.008
  1. APG admission plasma glucose, MACE major adverse cardiac event, DM diabetes mellitus. Other abbreviations as in Table 1